Board of Directors
Scientific Advisory Board
Clinical Development Strategy
Why Pancreatic Cancer
The AZT Therapeutics Program
Azure Health Technology Limited Initial Public Offering (IPO)
The Directors are pleased to announce that Azure Health Technology Limited's Initial Public Offering which opened on Friday 5 March 2021 has been extended to close no later than Friday, 16 April 2021.
For more information, please refer to the prospectus.
ABN 35 111 082 485